Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Julphar
Cerilliant
Accenture
Teva
Dow
Covington
Cantor Fitzgerald
Boehringer Ingelheim
Fuji

Generated: August 20, 2017

DrugPatentWatch Database Preview

NEOMYCIN SULFATE Drug Profile

« Back to Dashboard

Which patents cover Neomycin Sulfate, and when can generic versions of Neomycin Sulfate launch?

Neomycin Sulfate is a drug marketed by Teva, Lannett, X Gen Pharms, Lannett Holdings Inc, Bristol Myers Squibb, Oman Pharm Products, Roxane, Lilly, Sandoz, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm. and is included in twenty NDAs.

The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are eighteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.

Summary for Tradename: NEOMYCIN SULFATE

Patents:0
Applicants:14
NDAs:20
Suppliers / Packagers: see list7
Bulk Api Vendors: see list77
Clinical Trials: see list666
Patent Applications: see list9,882
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEOMYCIN SULFATE at DailyMed

Pharmacology for Tradename: NEOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL060304-001Approved Prior to Jan 1, 1982AARXNoYes► Subscribe► Subscribe► Subscribe
Fougera
NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
neomycin sulfate; triamcinolone acetonide
OINTMENT;TOPICAL062608-001May 23, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Roxane
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL062173-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings Inc
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL204435-001Jun 10, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC062714-001Jul 21, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Moodys
Daiichi Sankyo
Queensland Health
McKinsey
Mallinckrodt
Cerilliant
Harvard Business School
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot